DOI:
10.1055/s-00049561
South Asian Journal of Cancer
LinksClose Window
References
Long GV, Hauschild A, Santinami M. et al
Adjuvant dabrafenib plus trametinib in stage III BRAF-mutated melanoma.
N Engl J Med 2017;
377 (19) 1813-1823
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.